Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Guglielmini

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Pharmacological Reports : PR|February 25, 2025
Effects of 3,5,4'-tri-[4-(nitrooxy)butanoyl]oxy resveratrol, a new nitric oxide-releasing derivative of resveratrol, on platelet activationGiuseppe Guglielmini, Emanuela Berardi, Federica Messina, et al.
Vascular Medicine (London, England)|April 13, 2021
Walking-induced endothelial dysfunction predicts ischemic cardiovascular events in patients with intermittent claudicationRino Migliacci, Giuseppe Guglielmini, Chiara Busti, et al.
The Journal of Nutritional Biochemistry|November 30, 2010
Effects of resveratrol and other wine polyphenols on vascular function: an updatePaolo Gresele, Chiara Cerletti, Giuseppe Guglielmini, et al.
Haematologica|August 19, 2021
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathwayLoredana Bury, Emanuela Falcinelli, Anna Maria Mezzasoma, et al.
Fitoterapia|July 22, 2015
Effect of substituted stilbenes on platelet functionFederica Messina, Giuseppe Guglielmini, Massimo Curini, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 8, 2011
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intakeSilvia Giannini, Emanuela Falcinelli, Loredana Bury, et al.
Thrombosis Research|December 9, 2022
Usefulness of global tests of primary hemostasis in the initial screening of mild/moderate bleeding disorders for orienting towards von Willebrand disease or inherited platelet functions disordersAndrea Baccolo, Emanuela Falcinelli, Anna Maria Mezzasoma, et al.
Haematologica|July 29, 2017
Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?Mariachiara Borghi, Giuseppe Guglielmini, Anna Maria Mezzasoma, et al.
European Journal of Pharmacology|July 17, 2007
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic propertiesStefania Momi, Francesco Impagnatiello, Massimiliano Guzzetta, et al.
Internal and Emergency Medicine|January 7, 2022
Increased plasma PCSK-9 is associated with restenosis in patients undergoing carotid endarterectomyEmanuela Falcinelli, Giacomo Isernia, Giuseppe Guglielmini, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Pharmacological Reports : PR|February 25, 2025
Effects of 3,5,4'-tri-[4-(nitrooxy)butanoyl]oxy resveratrol, a new nitric oxide-releasing derivative of resveratrol, on platelet activationGiuseppe Guglielmini, Emanuela Berardi, Federica Messina, et al.
Vascular Medicine (London, England)|April 13, 2021
Walking-induced endothelial dysfunction predicts ischemic cardiovascular events in patients with intermittent claudicationRino Migliacci, Giuseppe Guglielmini, Chiara Busti, et al.
The Journal of Nutritional Biochemistry|November 30, 2010
Effects of resveratrol and other wine polyphenols on vascular function: an updatePaolo Gresele, Chiara Cerletti, Giuseppe Guglielmini, et al.
Haematologica|August 19, 2021
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathwayLoredana Bury, Emanuela Falcinelli, Anna Maria Mezzasoma, et al.
Fitoterapia|July 22, 2015
Effect of substituted stilbenes on platelet functionFederica Messina, Giuseppe Guglielmini, Massimo Curini, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 8, 2011
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intakeSilvia Giannini, Emanuela Falcinelli, Loredana Bury, et al.
Thrombosis Research|December 9, 2022
Usefulness of global tests of primary hemostasis in the initial screening of mild/moderate bleeding disorders for orienting towards von Willebrand disease or inherited platelet functions disordersAndrea Baccolo, Emanuela Falcinelli, Anna Maria Mezzasoma, et al.
Haematologica|July 29, 2017
Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?Mariachiara Borghi, Giuseppe Guglielmini, Anna Maria Mezzasoma, et al.
European Journal of Pharmacology|July 17, 2007
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic propertiesStefania Momi, Francesco Impagnatiello, Massimiliano Guzzetta, et al.
Internal and Emergency Medicine|January 7, 2022
Increased plasma PCSK-9 is associated with restenosis in patients undergoing carotid endarterectomyEmanuela Falcinelli, Giacomo Isernia, Giuseppe Guglielmini, et al.
Pageof 5